ADAM10 and Alzheimer disease: NrCAM is a physiological substrate for disintegrin and metalloprotease 10 (ADAM10), which is involved in amyloid precursor protein (APP) cleavage, so may exert a protective role in AD and therefore become a potential therapeutic target [22].